Plusvital Launch New Tests


Mike Shelly | Plusvital

Plusvital, the company that acquired the equine genomic testing company Equinome earlier in December of 2015, has launched four new genetic tests aimed at the global Thoroughbred community. The new range of tests were developed by analysing 48,000 genetic markers from over 4,000 horses representing 739 unique sires and including over 800 black-type winners. The new products include the following:

Elite Performance v3.0: This genetic test achieves higher strike rates by identifying the highest genetic potential for elite breeding and racecourse success. The test provides three outputs. A Genomic Racing Value, which indicates a horse's potential to be an elite racehorse. A Genomic Breeding Value which represents the potential of a broodmare or stallion to produce offspring with a higher potential for elite success. A Genomic Inbreeding Value which evaluates the actual level of inbreeding in a thoroughbred horse.


Distance Plus v1.0: This genetic test refines the optimum race distance for a Thoroughbred horse through analysis of a more complex range of genetic markers, separating horses into short or long C:C, C:T or T:T.


Raced/Unraced v1.0: This genetic test identifies foals with the greatest potential to have a racecourse start as a 2- or 3-year-old.


Dirt v Turf v1.0: This test indicates genetic affinity of an individual horse for achieving best win on a dirt or turf surface.

Mike Shelly, CEO, Plusvital, said, “The launch of these new genetic tests by Plusvital is a large step forward in terms of the amount of information we can provide to breeders, owners and trainers from their horses' DNA. Our clients are already using genetic test information to inform their breeding and racing decisions and the additional information in the new tests will further strengthen the use of this technology across the industry where it is being used as a tool to complement existing horsemanship and pedigree analysis.”


Not a subscriber? Click here to sign up for the daily PDF or alerts.


Never miss another story from the TDN

Click Here to sign up for a free subscription.